PTGS2 and ovarian cancer: In the present study, we postulate that a combination of COX-1 and COX-2 selective inhibitors should reduce the growth of tumors more effectively than either agent alone in nude female mice transplanted with a human ovarian cancer SKOV-3 cell line.